Report : Microtome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Microtome Instruments, Microtome Accessories); Technology (Manual Microtomes, Semi-automated Microtomes, Fully Automated Microtomes); End User (Hospitals, Clinical Laboratories, Other End Users)
Market for Microtome Instruments to Grow at Highest CAGR during 2020-2027
According to our latest study on “Microtome Market Forecast to 2027- COVID-19 Impact and Global Analysis- by product, technology, and end user,” the market was valued at US$ 132.6 million in 2019 and is projected to reach US$ 204.3 million by 2027; it is expected to grow at a CAGR of 5.7% during 2020-2027. The report highlights trends prevailing in the global microtome market, and the drivers and hindrances pertaining to the market growth.
The global microtome market, based on product, is segmented into microtome instruments and microtome accessories. The microtome instruments segment held a larger share of the market in 2019, and it is further estimated to register a higher CAGR during the forecast period; this projected growth is ascribed to the increasing product launches, growing adoption of microtome in histology labs, and high use of these instruments by healthcare providers in cancer diagnosis.
The growth of the microtome market is attributed to factors such as rising prevalence of cancer and increasing adoption of digital pathology. However, the lack of adoption of microtomes in low-income countries restrains the growth of the market. PHC Holdings Corporation, MEDITE Medical GmbH, Sakura Finetek USA, Inc., Leica Biosystems Nussloch GmbH (Danaher), Histo-Line Laboratories, SLEE medical GmbH, Diapath S.p.A., Amos Scientific Pty Ltd, Boeckeler Instruments, Inc., and SM Scientific Instruments Pvt. Ltd are among the leading companies operating in the global microtome market.
The report segments global microtome market as follows:
By End User